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Abstract: Avian influenza virus stocks (A/chicken/Iran/259/1998/(H9N2)) were propagated in the allantoic cavities of 10-day-old
embryonated chicken eggs. The harvested suspension was concentrated by polyethylene glycol 6000. Concentrated samples were
layered onto sucrose gradient (30%-60%). Both hemagglutinin and neuraminidase were solubilized from purified viruses with
Triton X-100 across 30% sucrose gradient. NA was isolated from HA and other viral proteins by affinity chromatography on N-(paminophenyl)oxamic acid. Fractions that had high NA activity and did not show HA activity were pooled and analyzed by
neuraminidase inhibition and SDS-PAGE. No viral protein bands were detected, except for a single band in the position of NA. NA
activity of purified protein was 3.8 × 104 NA units. Enzymatic activity of neuraminidase purified by this procedure decreased sharply
above 48 °C. For preparation of antisera, rabbits were immunized with purified NA and Freund’s adjuvant at 3-week intervals, and
sera were collected 7 days after boosting. The purified neuraminidase produced a significant antibody response in agar gel
precipitation. No reaction was observed with neuraminidase-specific antiserum or H9-HA of the same virus.
Key Words: Avian influenza, neuraminidase, antiserum

Introduction
There are 2 types of glycoprotein projections that
cover the surface of influenza A viruses: 1) rod-shaped
trimers of hemagglutinin, and 2) mushroom-shaped
tetramers of neuraminidase. At present, 15
hemagglutinin (HA) subtypes (H1-15) and 9
neuraminidase (NA) subtypes (N1-9) of influenza A
viruses have been identified (1-3). NA accounts for about
5%-10% of the virus protein, exists as spikes on the
surface of the virion, and possesses a hydrophilic area
(2,4).
HA and NA components may be separated from
residual intact sub-viral particles using conventional
methods for the separation of materials having different
sizes or density, for example, by gradient centrifuging,
using sucrose or glutamate media followed by
fractionating of the gradients, sedimentation, molecular
sieve chromatography, or by pelleting in an
ultracentrifuge (5).

Determination of the subtype of influenza A virus is
the first step in the characterization of new isolated
influenza viruses and is an essential part of early detection
for prevention and eradication programs. This is
traditionally done by HA inhibition (HI) and NA inhibition
(NI) tests using specific antisera raised in ferrets, sheep,
rabbits, or chickens (6).
Unfortunately, monospecific antisera for avian
influenza that are appropriate for use in diagnostic
serological applications like NI and agar gel precipitation
(AGP) are commercially unavailable in Iran. However,
affinity chromatography methods have been developed
and standardized for the safe and reproducible
production of the NA antigen of influenza virus for the
preparation of monospecific antiserum in rabbits.
Many approaches have been used to purifying the NA
antigen (7). Other components may be isolated for
further study of other methods (8-10).
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Materials and Methods
Extraction and purification of HA and NA
The virus, A/chicken/Iran/259/1998/(H9N2), was
grown in 10-day-old embryonated chicken eggs. The
eggs were candled daily to check for embryo mortality,
and allantoic fluid was clarified by absorption and elution
from chicken erythrocytes, followed by centrifugation at
3500 rpm for 15 min. Then the fluids were tested for the
presence of influenza virus and differentiated from other
HA positive microorganisms by the hemagglutination
inhibition test and electron microscopy (EM), and
differentiated from Mycoplasma spp. by the PPLO test.
All viruses were frozen at –70 °C until use.
The virus was concentrated by precipitation with 10%
(w/v) polyethylene glycol 6000 and then purified by
centrifugation at 9000 rpm for 50 min. Subsequently, a
concentrated sample layered over an isopycnic
(equilibrium) sucrose density gradient (30%-60%) was
made in a Beckman 25 × 76 mm ultraclear tube
(Beckman Instruments, Inc., Fullerton, CA, USA) and
centrifuged at 20,000 rpm for 4 h. Sucrose was removed
using dialysis against Tris-NaCl-EDTA (TNE) buffer. Then
Triton X-100 was added to the virus concentrate in the
form of an aqueous solution to make a final concentration
of 1%-3% (v/v), which was then stirred and warmed at
30 °C for 2 h.
The virus preparation was centrifuged at 20,000 rpm
for 2 h to separate core proteins from surface proteins.
The rich supernatant HA/NA was removed and the pH
adjusted to 5.5 using acetic acid.
Chromatographic separation of HA from NA
NA and HA were extracted from Triton X-100 and the
disrupted virus was passed through an oxamic acid
agarose column (11). An N-(p-aminophenyl)oxamic acid
(Sigma, St Louis, MO) agarose column was activated by
washing with 5 column volumes of 0.1 M sodium
bicarbonate solution containing 0.1% Triton X-100
adjusted to pH 9.1, followed by 5 column volumes of
0.05 M sodium acetate solution containing 0.1% Triton
X-100 adjusted to pH 5.5. The HA/NA-rich supernate was
loaded on the column, and the column was washed with
0.15 M sodium acetate solution and 0.1% Triton X-100
(pH 5.5), eluting the bulk of HA. Bound NA was eluted
from the column with 0.1 M sodium bicarbonate solution,
0.1% Triton X-100, and 0.002 M CaCl (pH 9.1) (11).
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After chromatography, individual fractions were
dialyzed against the sodium acetate buffer (0.05 M
sodium acetate, 2 mM NaCl, 0.2 mM EDTA (pH: 7.0)) for
72 h to remove any residual detergent, and each fraction
was assayed for NA activity and HA activity by employing
fetuin (12). Fractions with optimal activity and the
various preparations described above were analyzed by
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) under non-reducing conditions as described
by O’Farrell (13). Gels were silver stained according to
Morrissey and analyzed to ensure that the preparations
were free of proteins (14). Total protein in the
preparation was measured by the method of Bradford as
described by Bailey (15).
Thermal and cryostability
The NA sample was warmed at the rate of 1° min-1
from 35-75 °C. Aliquots were taken at 5 °C intervals,
rapidly cooled in an ice water bath, and tested for NA
enzymatic activity (16).
Preparation of anti-neuraminidase sera
Rabbits (New Zealand White strain) were immunized
by multi-site subcutaneous injection of 200 µg purified
NA in Freund’s complete adjuvant. At 21 days postinoculation they were boosted by subcutaneous injection
with 100 µg NA in Freund’s incomplete adjuvant. The
rabbits were bled 7 days after the second injection; sera
were collected for analysis by agar gel precipitation (AGP)
against purified NA, detergent-disrupted whole virus, and
purified H9-HA of the same virus (12,15).

Results
The Triton X-100 supernatant was devoid of matrix
protein and contained most of the HA and NA (Figure
1b). Protein recovery during the purification procedure is
shown in the Table; 55.1% of the total protein was
solubilized by Triton X-100 and 8.3% of the total viral
protein was associated with the NA peak obtained after
oxamic acid affinity chromatography.
A slightly acidic buffer was used for the adsorption
cycle, resulting in increased column capacity. The elution
profile for the separation of N2 NA from H9 HA on an N(p-aminophenyl)oxamic acid column is shown in Figure 2.
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Figure 2. Affinity chromatography of Triton X-100 solubilized HA-NA
from H9N2 virus preparation on an N-(p-aminophenyl)
M

oxamic acid column.

Figure 1. Analysis of influenza virus proteins with silver staining of
10% SDS-PAGE. Electrophoresis was performed under nonreducing conditions.
a.

A/chicken/Iran/259/1998/(H9N2) influenza virus,
demonstrating the relative molecular weight of influenza
virus proteins, NP, 56 KDa; M1, 27 KDa: NA, 220 KDa.

b. Triton X-100 supernatant.
c.

In this study SDS-PAGE was used for confirmation of
the isolated NA. With polyacrylamide gel electrophoresis,
as shown in Figure 1c, NA migrated as a single high
molecular weight component (220 kDa) and revealed no
trace of other proteins.
The thermal stability and enzymatic activity of N2NA
are shown in Figure 3.

N2-NA purified from Iranian avian influenza virus
(H9N2).

Table. Protein recovery during NA purification from H9N2.
Purification stage

Protein

Recovery

Total (mg)

(%)

Total virus preparation

38.3

100

Supernatant

21.1

55.1

Oxamic acid Affinity chromatography

3.2

8.3

In order to determine specificity and to assess the
ultimate purity of NA, antisera were prepared against NA
in rabbits. Typical results shown in Figure 4 demonstrate
that isolated NA developed a single well-defined precipitin
line against NA-specific antiserum produced by the
method represented in this paper. No reaction was
observed with NA-specific antiserum and H9-HA of the
same virus.

Discussion

Under the chromatographic conditions of the NA
absorption buffer, the HA passed through the column in
the exclusion volume and contained 93% of the sample
protein and < 8% of the sample NA activity. NA was
eluted in the flow-through volume with no detectable
hemagglutinin activity. Fractions from either source that
had high NA activity (3.8 × 104 NA units) and did not
show hemagglutination for chicken erythrocyte were
pooled and analyzed by silver staining of SDS-PAGE.

The neuraminidase purification technique described in
this paper yields an enzymatically active NA (Figure 3).
Because both surface antigens belong to membraneassociated glycoprotein with similar biochemical
properties, separation of the 2 components is difficult
(7,17) and success of either procedure varies with
different virus strains. No universally applicable method
was found for the isolation of purified HA and NA
antigens from all strains of influenza virus.
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Figure 3. Thermal stability of purified NA. The sample was heated at
the rate of 1 °C min-1 and aliquots were taken every 5 °C
from 35-75 °C were tested for NA enzymatic activity.

Separation of HA and NA molecules with
chromatography is difficult because in their trimeric and
tetrameric forms, HA and NA molecules, respectively, are
close in molecular weight and have affinity for similar
substrates. Nevertheless, it has been carried out, both
with affinity (9-12,16) and ion exchange
chromatographic procedures (7). Purification of NA, HA,
or both is dependent on the development of conditions to
exploit biochemical differences between 2 antigens. In the
present study satisfactory separation of the 2 major
antigens was obtained by affinity chromatography. The
use of N-(p-aminophenyl)oxamic acid agarose as a
selective absorbent for influenza or bacterial NA has been
demonstrated in other studies (5,11). Affinity
chromatography separates NA from HA. More than 90%
of NA is removed from a typical HA-NA preparation. The
collected NA in a single column cycle is virtually pure. This
technique has been particularly successful for the
purification of NA, perhaps because these enzymes can be
subjected to relatively rigorous conditions of detergent
exposure without denaturation. The advantages of these
procedures over the conventional methods of enzyme
purification include greater speed and yield, and a higher
degree of purity.
The lack of HA activity in the purified virus enzymes
further indicates that NA and HA are separated. The use
of Triton X-100 stabilizes and maintains the solubility of
NA and retains its activity. We found that with detergent
concentration as high as 3%, NA and HA were fully
2+
dissociated from one another. Moreover, Ca in dialysis
buffer stabilizes viral NA enzymatic activity (18) and
immunogenicity (E.D. Kilbourne, unpublished results);
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Figure 4. Agar gel precipitation of antisera prepared against isolated
NA, HA of the same virus, and disrupted H9N2 virus. Isolated
NA and the virus developed a single, well-defined precipitin
line against NA-specific antiserum. No reaction was observed
with NA-specific antiserum and H9-HA of the same virus.

however, the enzyme appeared to be equally stable with
or without additional Triton X-100 (5).
Enzymatic activity of NA purified by this procedure
decreased sharply above 48 °C (Figure 3).
Only a few attempts have been made to determine the
subtypes of influenza A viruses by methods other than HI
and NI, either after passage in cell culture or directly from
clinical specimens. More recently, the reverse
transcriptase PCR method has been applied for the typespecific and subtype-specific detection of influenza virus
RNA in clinical specimens (19).
The antigens were analyzed for their ability to induce
specific antibody formation in rabbits. Antisera raised
against purified NA by the method described in this report
gave reactions to NA and disrupted H9N2 virus in AGP
(Figure 4). The results indicate that the monospecific
anti-HA antiserum neither neutralized NA activity nor
gave a precipitation line by the AGP test against NA. The
antiserum produced by injection of purified viral HA
(unpublished results) neutralized HA activity and gave
precipitin lines when AGP tests were performed, and
there was no cross-reaction against viral NA.
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We also observed that highly specific NA antiserum
was a valuable experimental tool in determining the
significance of function or the role of the enzyme during
virus multiplication (unpublished results).
We demonstrated that the NA antisera produced by
this method are high quality reagents and suitable for
serological applications in the diagnostic laboratory.
The present rapid, simple, and efficient method for
preparation of NA from influenza virus should be useful
not only in producing live NA-specific vaccines based upon
purified NA against highly pathogenic avian influenza, but
also for the preparation of NA for the study of structure
activity. Furthermore, the antigens are suitable for use in
either NI or agar gel precipitation and the optimized
protocols can be directly applied to produce antigens

from new or emerging influenza viruses. A study of the
efficiency of N2-specific vaccines in chickens and the
detection of NA-specific antibody by ELISA and
immunoblotting procedures are currently being
undertaken.
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